Predicting bleeding risk in PAD patients on antiplatelets using TEG coagulation testing
High platelet inhibition (>86.4%) and low MA ADP (<31.9%) may serve as indicators of bleeding risk in PAD patients on antiplatelets, highlighting the potential utility of TEG-PM in guiding personalized antithrombotic management.
Authors
- Mounika Naidu Boya (ORCID: https://orcid.org/0000-0002-1635-1118)
- Anahita Dua (ORCID: https://orcid.org/0000-0002-3349-4233)
- Adriana A Rodriguez Alvarez (ORCID: https://orcid.org/0000-0002-5394-3323)
- Isabella Ferlini Cieri (ORCID: https://orcid.org/0000-0002-6163-1055)
- Shiv Patel (ORCID: https://orcid.org/0009-0008-2580-436X)
Institutions
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Journal of Surgery and Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.26502/jsr.10020456
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health